Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis

Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis have?

Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis has 30 citations in the OpenAlex counts ScholarIQ stores.

When was Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis published?

Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis has 2017 year in the ScholarIQ index.

What is the open-access status of Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis?

Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis has gold oa status in the ScholarIQ index.

What is the DOI of Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis?

The DOI for Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis is on the source record.

What is the PMID of Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis?

The PMID for Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis is on the source record.

What is the OpenAlex record for Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis?

The OpenAlex for Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis is on the source record.